athenahealth, Inc. (NASDAQ:ATHN) Shares Sold by Sei Investments Co.
Sei Investments Co. cut its position in shares of athenahealth, Inc. (NASDAQ:ATHN) by 8.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 93,858 shares of the health services provider’s stock after selling 9,209 shares during the period. Sei Investments Co.’s holdings in athenahealth were worth $13,192,000 as of its most recent filing with the SEC.
Several other institutional investors also recently made changes to their positions in ATHN. Norges Bank bought a new position in shares of athenahealth during the fourth quarter worth $20,750,000. Rockefeller Financial Services Inc. raised its position in shares of athenahealth by 13.1% in the first quarter. Rockefeller Financial Services Inc. now owns 8,445 shares of the health services provider’s stock worth $952,000 after buying an additional 975 shares during the period. State Street Corp raised its position in shares of athenahealth by 3.7% in the first quarter. State Street Corp now owns 502,823 shares of the health services provider’s stock worth $56,662,000 after buying an additional 17,718 shares during the period. UBS Asset Management Americas Inc. raised its position in shares of athenahealth by 14.0% in the first quarter. UBS Asset Management Americas Inc. now owns 22,931 shares of the health services provider’s stock worth $2,584,000 after buying an additional 2,820 shares during the period. Finally, Teachers Advisors LLC raised its position in shares of athenahealth by 3.0% in the fourth quarter. Teachers Advisors LLC now owns 74,094 shares of the health services provider’s stock worth $7,792,000 after buying an additional 2,190 shares during the period.
Shares of athenahealth, Inc. (ATHN) opened at 142.01 on Wednesday. The company’s 50-day moving average is $143.35 and its 200 day moving average is $124.81. athenahealth, Inc. has a 1-year low of $90.11 and a 1-year high of $158.66. The stock has a market cap of $5.67 billion, a P/E ratio of 180.22 and a beta of 1.77.
athenahealth (NASDAQ:ATHN) last posted its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.39 by $0.12. The business had revenue of $301.10 million during the quarter, compared to the consensus estimate of $298.68 million. athenahealth had a net margin of 2.80% and a return on equity of 6.91%. athenahealth’s quarterly revenue was up 15.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.34 EPS. Equities research analysts anticipate that athenahealth, Inc. will post $1.91 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This story was first published by Daily Political and is the property of of Daily Political. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.dailypolitical.com/2017/08/09/athenahealth-inc-nasdaqathn-shares-sold-by-sei-investments-co.html.
A number of equities analysts have weighed in on ATHN shares. William Blair reiterated a “market perform” rating on shares of athenahealth in a report on Friday, July 21st. Cantor Fitzgerald reiterated a “buy” rating and issued a $118.00 price target (down previously from $135.00) on shares of athenahealth in a report on Thursday, April 27th. Argus started coverage on shares of athenahealth in a report on Friday, July 7th. They issued a “hold” rating on the stock. Citigroup Inc. reiterated a “buy” rating and issued a $163.00 price target (up previously from $128.00) on shares of athenahealth in a report on Monday, June 5th. Finally, J P Morgan Chase & Co set a $136.00 price target on shares of athenahealth and gave the company a “hold” rating in a report on Wednesday, July 19th. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and thirteen have given a buy rating to the company. athenahealth presently has an average rating of “Hold” and an average price target of $148.64.
In related news, CEO Jonathan Bush sold 4,000 shares of the company’s stock in a transaction on Thursday, May 18th. The shares were sold at an average price of $125.85, for a total transaction of $503,400.00. Following the completion of the transaction, the chief executive officer now directly owns 319,807 shares in the company, valued at approximately $40,247,710.95. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Bradford Kyle Armbrester sold 2,431 shares of the company’s stock in a transaction on Thursday, May 18th. The shares were sold at an average price of $130.00, for a total transaction of $316,030.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 22,905 shares of company stock valued at $3,120,107. 3.20% of the stock is owned by insiders.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc. (NASDAQ:ATHN).
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.